Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MTVA
MTVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MTVA News
Rita Ferro Takes Charge of Disney's Global Advertising
16h ago
CNBC
MetaVia's DA-1726 Shows Significant Weight Loss Results
4d ago
PRnewswire
MetaVia's DA-1726 Shows Significant Weight Loss Results
4d ago
Newsfilter
Biotech Stocks Surge with Akari Leading the Rally
5d ago
NASDAQ.COM
Biotech Sector Attracts Investor Attention Amid Innovation
May 22 2026
Globenewswire
MetaVia Publishes Research Supporting Vanoglipel's Anti-Fibrotic Potential
May 20 2026
PRnewswire
Biotech Stocks Surge Significantly
May 20 2026
NASDAQ.COM
MetaVia's Three Key Studies Accepted at ADA Conference
May 18 2026
PRnewswire
MetaVia Reports Q1 2026 Financial Results
May 14 2026
seekingalpha
MetaVia's DA-1726 to be Presented at EASL Congress
May 11 2026
PRnewswire
MetaVia's DA-1726 to be Presented at EASL Congress
May 11 2026
Newsfilter
MetaVia Initiates Phase 1 Trial for DA-1726 in Obesity
Apr 10 2026
PRnewswire
MetaVia Initiates Phase 1 Trial for DA-1726
Apr 10 2026
Newsfilter
MetaVia Reports FY 2025 Financial Results with Significant Losses
Mar 26 2026
seekingalpha
MetaVia Reports Phase 1 Data for DA-1726 Indicating Best-in-Class Potential
Mar 26 2026
PRnewswire
MetaVia Unveils DA-1726 Phase 1 Data, Showcasing Best-in-Class Potential
Mar 26 2026
Newsfilter
Show More News
